EMEA-001662-PIP01-14-M03

Key facts

Active substance
Palovarotene
Therapeutic area
Other
Decision number
P/0144/2020
PIP number
EMEA-001662-PIP01-14-M03
Pharmaceutical form(s)
Capsule, hard
Condition(s) / indication(s)
Treatment of fibrodysplasia ossificans progressiva
Route(s) of administration
Oral use
Contact for public enquiries
Ipsen Pharma

E-mail: abdelali.majdi@ipsen.com
Tel.: +33 158335427

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating